𝔖 Bobbio Scriptorium
✦   LIBER   ✦

RANKL Expression, Function, and Therapeutic Targeting in Multiple Myeloma and Chronic Lymphocytic Leukemia

✍ Scribed by Schmiedel, B. J.; Scheible, C. A.; Nuebling, T.; Kopp, H.-G.; Wirths, S.; Azuma, M.; Schneider, P.; Jung, G.; Grosse-Hovest, L.; Salih, H. R.

Book ID
118001094
Publisher
American Association for Cancer Research
Year
2012
Tongue
English
Weight
954 KB
Volume
73
Category
Article
ISSN
0008-5472

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Serum bactericidal and opsonic activitie
Serum bactericidal and opsonic activities in chronic lymphocytic leukemia and multiple myeloma
✍ Dr. Emin Kansu; Erdal Akalin; Cahid Civelek; Oktay Tekesin; Yahya Lalell; DinΓ§er πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 352 KB πŸ‘ 1 views

Susceptibility to infection is widely recognized as the major cause of morbidity and mortality in patients with CLL and MM. The present study was designed to investigate the serum bactericidal (SBA) and serum opsonic activities (SOA) in 12 CLL and 12 MM patients, and results were compared to 20 norm

Therapeutic cytapheresis in chronic lymp
Therapeutic cytapheresis in chronic lymphocytic leukemia
✍ G. E. Marti; T. Folks; D. L. Longo; H. Klein πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 589 KB

The role of therapeutic reductive lymphapheresis in 59 patients with chronic lymphocytic leukemia (CLL) was reviewed. Reduction in lymphocytosis, lymphadenopathy and hepatosplenomegaly was noted in 50%-60% of the patients studied. In addition to mobilization of the lymphoid tumor load, 40% of the pa

Concurrent B-cell chronic lymphocytic le
Concurrent B-cell chronic lymphocytic leukemia and multiple myeloma treated successfully with lenalidomide
✍ Sridhar Srinivasan; Charles A. Schiffer πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 91 KB

The occurrence of multiple myeloma and chronic lymphocytic leukemia in the same patient is very uncommon. The immunomodulatory agent lenalidomide has been shown to have high response rates in multiple myeloma and appears to be quite active in advanced CLL. We report two patients with concurrent CLL